230 related articles for article (PubMed ID: 14597771)
1. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF.
Nanba D; Mammoto A; Hashimoto K; Higashiyama S
J Cell Biol; 2003 Nov; 163(3):489-502. PubMed ID: 14597771
[TBL] [Abstract][Full Text] [Related]
2. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
Toki F; Nanba D; Matsuura N; Higashiyama S
J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells.
Ozeki K; Tanida S; Morimoto C; Inoue Y; Mizoshita T; Tsukamoto H; Shimura T; Kataoka H; Kamiya T; Nishiwaki E; Ishiguro H; Higashiyama S; Joh T
PLoS One; 2013; 8(2):e56770. PubMed ID: 23451083
[TBL] [Abstract][Full Text] [Related]
4. Roles of charged amino acid residues in the cytoplasmic domain of proHB-EGF.
Nanba D; Toki F; Higashiyama S
Biochem Biophys Res Commun; 2004 Jul; 320(2):376-82. PubMed ID: 15219838
[TBL] [Abstract][Full Text] [Related]
5. Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor.
Nanba D; Higashiyama S
Cytokine Growth Factor Rev; 2004 Feb; 15(1):13-9. PubMed ID: 14746810
[TBL] [Abstract][Full Text] [Related]
6. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
[TBL] [Abstract][Full Text] [Related]
7. Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane.
Hieda M; Isokane M; Koizumi M; Higashi C; Tachibana T; Shudou M; Taguchi T; Hieda Y; Higashiyama S
J Cell Biol; 2008 Feb; 180(4):763-9. PubMed ID: 18299347
[TBL] [Abstract][Full Text] [Related]
8. The carboxyl-terminal fragment of pro-HB-EGF reverses Bcl6-mediated gene repression.
Kinugasa Y; Hieda M; Hori M; Higashiyama S
J Biol Chem; 2007 May; 282(20):14797-806. PubMed ID: 17392284
[TBL] [Abstract][Full Text] [Related]
9. Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion.
Shimura T; Yoshida M; Fukuda S; Ebi M; Hirata Y; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Higashiyama S; Joh T
BMC Cancer; 2012 May; 12():205. PubMed ID: 22646534
[TBL] [Abstract][Full Text] [Related]
10. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.
Goishi K; Higashiyama S; Klagsbrun M; Nakano N; Umata T; Ishikawa M; Mekada E; Taniguchi N
Mol Biol Cell; 1995 Aug; 6(8):967-80. PubMed ID: 7579712
[TBL] [Abstract][Full Text] [Related]
11. Trafficking of nuclear heparin-binding epidermal growth factor-like growth factor into an epidermal growth factor receptor-dependent autocrine loop in response to oxidative stress.
Kim J; Adam RM; Freeman MR
Cancer Res; 2005 Sep; 65(18):8242-9. PubMed ID: 16166300
[TBL] [Abstract][Full Text] [Related]
12. Insufficiency of pro-heparin-binding epidermal growth factor-like growth factor shedding enhances hypoxic cell death in H9c2 cardiomyoblasts via the activation of caspase-3 and c-Jun N-terminal kinase.
Uetani T; Nakayama H; Okayama H; Okura T; Higaki J; Inoue H; Higashiyama S
J Biol Chem; 2009 May; 284(18):12399-409. PubMed ID: 19193634
[TBL] [Abstract][Full Text] [Related]
13. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C.
Dethlefsen SM; Raab G; Moses MA; Adam RM; Klagsbrun M; Freeman MR
J Cell Biochem; 1998 May; 69(2):143-53. PubMed ID: 9548562
[TBL] [Abstract][Full Text] [Related]
14. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
15. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities.
Yamazaki S; Iwamoto R; Saeki K; Asakura M; Takashima S; Yamazaki A; Kimura R; Mizushima H; Moribe H; Higashiyama S; Endoh M; Kaneda Y; Takagi S; Itami S; Takeda N; Yamada G; Mekada E
J Cell Biol; 2003 Nov; 163(3):469-75. PubMed ID: 14597776
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor.
Mehta VB; Besner GE
J Immunol; 2003 Dec; 171(11):6014-22. PubMed ID: 14634113
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal visualization of proHB-EGF ectodomain shedding in living cells.
Inoue H; Sakaue T; Ozawa T; Higashiyama S
J Biochem; 2013 Jul; 154(1):67-76. PubMed ID: 23598347
[TBL] [Abstract][Full Text] [Related]
18. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
[TBL] [Abstract][Full Text] [Related]
19. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.
Nakamura K; Iwamoto R; Mekada E
J Cell Biol; 1995 Jun; 129(6):1691-705. PubMed ID: 7790364
[TBL] [Abstract][Full Text] [Related]
20. Soluble form of heparin-binding EGF-like growth factor contributes to retinoic acid-induced epidermal hyperplasia.
Kimura R; Iwamoto R; Mekada E
Cell Struct Funct; 2005; 30(2):35-42. PubMed ID: 16357442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
